The emerging novel coronavirus outbreak (COVID-19) represents a global challenge and a crucial query concerns its prevention and treatment.
Cardiologists should be aware of the risk of COVID-19 drug effects, interactions and toxicities as well of the current precautions and opportunities. Worldwide there is a great expectancy of a vaccine. Several clinical trials have already been conducted or are currently ongoing evaluating drugs and it will be important to helping treat COVID-19 patients
The world is desperately waiting for an effective and safe therapy for Covid-19 in the hope that an equally effective and safe vaccine will soon arriveDr. Salvatore Patanè, MD
Journal of Cardiology and Therapy
Journal of Cardiology and Therapy 2020; July; 7(1): 931-938 DOI: 10.17554/j.issn.2309-6861. 2020.07.180 http://www.ghrnet.org/index.php/jct/article/view/2930/3245
COVID-19 and the Cardiologist: Drug Therapeutic Options.